Patents by Inventor Ankur Saxena

Ankur Saxena has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20120057630
    Abstract: A method and apparatus encode and decode video by determining whether to use discrete cosine transform (DCT) and DST for each of the horizontal and vertical transforms. During encoding, an intra-prediction is performed based on an intra-prediction mode determined for an M×N input image block to obtain an M×N intra-prediction residue matrix (E). Based on the intra-prediction mode, each of a horizontal transform and a vertical transform is performed using one of DCT and DST according to the intra-prediction mode. During decoding, the intra-prediction mode is determined from an incoming video bitstream. The M×N transformed coefficient matrix of the error residue is obtained from the video bitstream using an inverse quantizer. Based on the intra prediction mode, one of DCT and DST is performed for each of an inverse vertical transform and an inverse horizontal transform.
    Type: Application
    Filed: September 6, 2011
    Publication date: March 8, 2012
    Inventors: Ankur Saxena, Felix Carlos Fernandes
  • Patent number: 7776816
    Abstract: Hypoxic tissue is preserved by prophylactically administering Stromal Derived Factor 1 Alpha (SDF-1?) before hypoxia induces cell death in the tissue.
    Type: Grant
    Filed: January 20, 2006
    Date of Patent: August 17, 2010
    Assignee: Board of Regents, The University of Texas System
    Inventors: Deepak Srivastava, Ankur Saxena
  • Patent number: 7531318
    Abstract: Integrin-linked kinase (ILK) and Akt/protein kinase B (PKB) are important mediators of signaling in cardiomyocytes and can both prevent damage and promote healing associated with ischemic injury to the heart. Thus, the present invention provides for methods of screening for agents that increase the expression of ILK and/or Akt/PKB. Methods of treatment based on such agents are also provided.
    Type: Grant
    Filed: August 22, 2005
    Date of Patent: May 12, 2009
    Assignee: Board of Regents, The University of Texas System
    Inventors: Deepak Srivastava, Ildiko Bock-Marquette, Ankur Saxena
  • Publication number: 20070172811
    Abstract: Hypoxic tissue is preserved by prophylactically administering Stromal Derived Factor 1 Alpha (SDF-1?) before hypoxia induces cell death in the tissue.
    Type: Application
    Filed: January 20, 2006
    Publication date: July 26, 2007
    Inventors: Deepak Srivastava, Ankur Saxena
  • Publication number: 20060121496
    Abstract: Integrin-linked kinase (ILK) and Akt/protein kinase B (PKB) are important mediators of signaling in cardiomyocytes and can both prevent damage and promote healing associated with ischemic injury to the heart. Thus, the present invention provides for methods of screening for agents that increase the expression of ILK and/or Akt/PKB. Methods of treatment based on such agents are also provided.
    Type: Application
    Filed: August 22, 2005
    Publication date: June 8, 2006
    Inventors: Deepak Srivastava, Ildiklo Bock-Marquette, Ankur Saxena